72 related articles for article (PubMed ID: 16645594)
1. Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections.
Kostka SL; Knop J; Konur A; Udey MC; von Stebut E
J Invest Dermatol; 2006 Jul; 126(7):1582-9. PubMed ID: 16645594
[TBL] [Abstract][Full Text] [Related]
2. Dectin-1 Positive Dendritic Cells Expand after Infection with
Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
Front Immunol; 2018; 9():263. PubMed ID: 29535708
[TBL] [Abstract][Full Text] [Related]
3. Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infection.
Kropf P; Herath S; Klemenz R; Müller I
Infect Immun; 2003 Apr; 71(4):1961-71. PubMed ID: 12654814
[TBL] [Abstract][Full Text] [Related]
4. IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection.
Colpitts SL; Dalton NM; Scott P
J Immunol; 2009 May; 182(9):5702-11. PubMed ID: 19380817
[TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.
Oghumu S; Stock JC; Varikuti S; Dong R; Terrazas C; Edwards JA; Rappleye CA; Holovatyk A; Sharpe A; Satoskar AR
Infect Immun; 2015 Jan; 83(1):67-76. PubMed ID: 25312956
[TBL] [Abstract][Full Text] [Related]
6. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function.
Morales-Tirado V; Sojka DK; Katzman SD; Lazarski CA; Finkelman FD; Urban JF; Fowell DJ
Blood; 2010 Apr; 115(17):3498-507. PubMed ID: 20032499
[TBL] [Abstract][Full Text] [Related]
7. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
[TBL] [Abstract][Full Text] [Related]
8. Identification of two distinct subpopulations of Leishmania major-specific T helper 2 cells.
Kropf P; Herath S; Tewari R; Syed N; Klemenz R; Müller I
Infect Immun; 2002 Oct; 70(10):5512-20. PubMed ID: 12228277
[TBL] [Abstract][Full Text] [Related]
9. Regulating human Th17 cells via differential expression of IL-1 receptor.
Lee WW; Kang SW; Choi J; Lee SH; Shah K; Eynon EE; Flavell RA; Kang I
Blood; 2010 Jan; 115(3):530-40. PubMed ID: 19965648
[TBL] [Abstract][Full Text] [Related]
10. Modeling Immune Response to
Ribeiro HAL; Maioli TU; de Freitas LM; Tieri P; Castiglione F
Front Cell Infect Microbiol; 2017; 7():309. PubMed ID: 28775959
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major.
Jones D; Elloso MM; Showe L; Williams D; Trinchieri G; Scott P
Infect Immun; 1998 Aug; 66(8):3818-24. PubMed ID: 9673267
[TBL] [Abstract][Full Text] [Related]
12. Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.
Theodos CM; Morris RV; Bishop JV; Jones JD; McMaster WR; Titus RG
Infect Immun; 2004 Aug; 72(8):4486-93. PubMed ID: 15271907
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor type I gene-deficient mice are less susceptible to Staphylococcus epidermidis biomaterial-associated infection than are wild-type mice.
Boelens JJ; van der Poll T; Zaat SA; Murk JL; Weening JJ; Dankert J
Infect Immun; 2000 Dec; 68(12):6924-31. PubMed ID: 11083815
[TBL] [Abstract][Full Text] [Related]
14. Floxed
Tongmuang N; Cai KQ; An J; Novy M; Jensen LE
Cells; 2024 May; 13(9):. PubMed ID: 38727323
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.
Novais FO; Carvalho AM; Clark ML; Carvalho LP; Beiting DP; Brodsky IE; Carvalho EM; Scott P
PLoS Pathog; 2017 Feb; 13(2):e1006196. PubMed ID: 28192528
[TBL] [Abstract][Full Text] [Related]
16. The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice.
Charmoy M; Hurrell BP; Romano A; Lee SH; Ribeiro-Gomes F; Riteau N; Mayer-Barber K; Tacchini-Cottier F; Sacks DL
Eur J Immunol; 2016 Apr; 46(4):897-911. PubMed ID: 26689285
[TBL] [Abstract][Full Text] [Related]
17. Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania.
Lima-Junior DS; Costa DL; Carregaro V; Cunha LD; Silva AL; Mineo TW; Gutierrez FR; Bellio M; Bortoluci KR; Flavell RA; Bozza MT; Silva JS; Zamboni DS
Nat Med; 2013 Jul; 19(7):909-15. PubMed ID: 23749230
[TBL] [Abstract][Full Text] [Related]
18. Multiomic profiling of cutaneous leishmaniasis infections reveals microbiota-driven mechanisms underlying disease severity.
Farias Amorim C; Lovins VM; Singh TP; Novais FO; Harris JC; Lago AS; Carvalho LP; Carvalho EM; Beiting DP; Scott P; Grice EA
Sci Transl Med; 2023 Oct; 15(718):eadh1469. PubMed ID: 37851822
[No Abstract] [Full Text] [Related]
19. The cytokine/chemokine response in
Maksoud S; El Hokayem J
Heliyon; 2023 Apr; 9(4):e15055. PubMed ID: 37082641
[TBL] [Abstract][Full Text] [Related]
20. Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to
Osero BO; Aruleba RT; Brombacher F; Hurdayal R
Cytokine X; 2020 Dec; 2(4):100043. PubMed ID: 33415318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
